Search research articles
Contact Us
Filters
Showing results (471-480 of 506) with videos related to
Page
of 51
Sort By:
Annals of the Rheumatic Diseases
|
November 2, 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
Florence Delestre, Pierre Charles, Alexandre Karras, et al.
Plos Genetics
|
July 14, 2011
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis
Yannick Allanore, Mohamad Saad, Philippe Dieudé, et al.
Annals of the Rheumatic Diseases
|
November 19, 2020
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
Renaud Felten, Valérie Devauchelle-Pensec, Raphaèle Seror, et al.
Journal of Translational Autoimmunity
|
January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Annals of the Rheumatic Diseases
|
January 28, 2021
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, et al.
RMD Open
|
March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]
Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open
|
November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
Simon Kuster, Suzana Jordan, Muriel Elhai, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
RMD Open
|
November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelines
Vanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Page
of 51
Search research articles
Search
Showing results (471-480 of 506) with videos related to
Sort By:
Page
of 51
Annals of the Rheumatic Diseases
|
November 2, 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
Florence Delestre, Pierre Charles, Alexandre Karras, et al.
Plos Genetics
|
July 14, 2011
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis
Yannick Allanore, Mohamad Saad, Philippe Dieudé, et al.
Annals of the Rheumatic Diseases
|
November 19, 2020
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
Renaud Felten, Valérie Devauchelle-Pensec, Raphaèle Seror, et al.
Journal of Translational Autoimmunity
|
January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Annals of the Rheumatic Diseases
|
January 28, 2021
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, et al.
RMD Open
|
March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]
Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open
|
November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
Simon Kuster, Suzana Jordan, Muriel Elhai, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
RMD Open
|
November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelines
Vanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Page
of 51